Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2005

View Archived Issues

Ligand updates progress of Targretin SPIRIT I and II trials

GB Therapeutics acquires CHF-1512 for Parkinson's disease

New phase III study investigates telavancin for hospital-acquired pneumonia

StaphVAX MAA accepted for review in Europe

FDA clears phase I trials to begin with human hookworm vaccine

LL-2113AD shows promise as add-on therapy for type 2 diabetes

First data on the benefits of letrozole as adjuvant therapy for early breast cancer

StreptAvax vaccine induces immune response to streptococcal antigens in healthy volunteers

Cytotoxic drugs reported to increase the antitumor effects of gene vaccines in a breast cancer model

Good safety profile found for KUR-1246 in pregnant sheep

Aradigm closes restructured licensing agreement with Novo Nordisk

Phenoxodiol receives fast track status for hormone-refractory prostate cancer

Norditropin NordiFlex now available in U.S.

Enrollment completed in phase III psoriasis trial for ISA-247

Pivotal study evaluates Acapodene for prostate cancer prevention

AL-108 enters phase I trials for Alzheimer's disease

UroGene to sell to Pierre Fabre uro-oncology programs, research platform

iNOS inhibitor, GW-274150, is protective in experimental colitis

New title added to the Drug R&D Backgrounders topic list - Scleroderma

Bemiparin is effective in a mouse asthma model

Novartis researchers claim PPAR modulators

Pfizer team describes novel series of PPARalpha activators

Lysophospholipid EDG receptor agonists disclosed in patents

Small-particle suspensions of anticonvulsant, antidementia and immunosuppressive agents

New combinations comprising modafinil reported by Cephalon

Kissei prepares and tests new agents for hyperuricemia

A novel series of immunosuppressants described in patent literature

Further data on use of Rho kinase inhibitor Y-27632 in hypertension

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...